'Bio Korea 2023' Opens Today: "Leap to Innovative Technology in the Hyperconnected Era"

‘Bio Korea 2023,’ the largest biohealth event in Korea, will be held for three days from the 10th to the 12th at COEX in Gangnam-gu, Seoul.

Bio Korea 2023 Poster. [Image provided by Korea Health Industry Development Institute]

Co-hosted by the Korea Health Industry Development Institute and Chungcheongbuk-do, this event is the largest domestic event that showcases Korea’s biohealth technology to the world and facilitates business discussions between domestic and international companies. This year’s theme is “Leap to New Growth Innovative Technologies in the Hyperconnected Era,” featuring programs such as business partnering, exhibitions, and conferences. Global pharmaceutical companies including Eli Lilly, Johnson & Johnson, and Merck will participate in the business partnering. Domestic companies such as SK Bioscience, Samsung Biologics, Green Cross, Chong Kun Dang, Hanmi Pharmaceutical, and LG Chem will also be present. Over 460 companies have pre-arranged more than 1,200 meetings for this business partnering event.

The number of exhibiting companies has significantly increased to 338 (including 102 overseas companies) compared to last year. The exhibition is organized by themes, including the Contract Manufacturing Organization (CMO) and Contract Development and Manufacturing Organization (CDMO) zones, Clinical Research Organization (CRO) zone, Advanced Regenerative Medicine Hall, and National Pavilion.

The conference will cover 21 sessions across 11 topics such as regenerative medicine, vaccines, and gene therapy. About 120 biohealth researchers and experts from 13 countries will participate as speakers to share the latest industry issues and business trends. Topics include “Digital Transformation” and “Next-Generation Clinical Trials,” which have emerged since the COVID-19 pandemic, as well as vaccines, regenerative medicine, and AI drug development. Key speakers include Jaejun Ryu, General Director of Naver Cloud, and Dr. Cynthia Burst from IQVIA, the world’s leading clinical service company. Other domestic and international experts will also participate as speakers.

At the Invest Fair, a total of 34 companies and institutions in the biohealth sector will introduce their technologies, management strategies, and visions to investors. Presentations and expert discussions will be held in five fields: regenerative medicine, digital therapeutics, therapeutics, vaccines, and medical devices. Additionally, a special session will provide information on global market entry, presenting investment trends by country and strategies for market entry from four countries.

Cha Sun-do, President of the Korea Health Industry Development Institute, said, “The biohealth industry will be the next-generation driving industry leading Korea in the future,” adding, “We hope this event will serve as a foundation for the domestic biohealth industry to enter the global market through active technology and information exchange between domestic and international companies.”

This content was produced with the assistance of AI translation services.